CRSP - CRISPR Therapeutics AG
IEX Last Trade
41.03
0 0%
Share volume: 17,929
Last Updated: Thu 26 Dec 2024 08:30:12 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$41.03
0.00
0.00%
Summary score
12%
Profitability
0%
Dept financing
4%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-3.52%
Return on assets
-3.33%
Return on sales
-201246.56%
Return on invested capital
-197.83%
Total debt ratio
13.6%
Debt ratio change over timeo
-1.18%
Current Ratio
17.88%
Quick Ratio
18.33%
Cash Position Ratio
17.23%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-2.91%
Return on assets
-3.33%
Return on sales
-9331.9%
Return on invested capital
-26.58%
Total debt ratio
16.16%
Debt ratio change over timeo
-1.18%
Current Ratio
16.29%
Quick Ratio
16.29%
Cash Position Ratio
15.56%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-5.59%
Return on assets
-5.76%
Return on sales
-27894.25%
Return on invested capital
-58.18%
Total debt ratio
14.56%
Debt ratio change over time
-0.65%
Current Ratio
17.81%
Quick Ratio
17.81%
Cash Position Ratio
17.72%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-94.18%
Return on assets
-94.56%
Return on sales
444317.04%
Return on invested capital
-7.94%
Total debt ratio
-117.51%
Debt ratio change over time
-1.18%
Current Ratio
-19.14%
Quick Ratio
-21.33%
Cash Position Ratio
-18.53%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CRSP | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -3.52% | 13.79% | 34.47% | 7.43% |
| Return on assets | -3.33% | 2.76% | 3.15% | 5.62% |
| Return on sales | -201246.56% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -197.83% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 13.6% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.18% | 308.97% | -6.99% | 1.18% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 16.29% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 16.29% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 15.56% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 3% | 6% | 14% |
| Short-term ratios | CRSP | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -2.91% | 13.77% | 13.25% | 3.8% |
| Return on assets | -3.33% | 2.43% | 1.89% | 3.09% |
| Return on sales | -9331.9% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -26.58% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 16.16% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.18% | 46.38% | -72.08% | 1.51% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 16.29% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 16.29% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 15.56% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 3% | 8% | 20% |